Hikma Completes Acquisition Of Custopharm

Apr 21, 2022•about 3 years ago

Acquiring Company

Hikma Pharmaceuticals PLC

Acquired Company

Hikma Pharmaceuticals PLC

London

Description

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces that it has completed its acquisition of Custopharm Inc. ('Custopharm') from Water Street Healthcare Partners ('Water Street'), following approval from the US Federal Trade Commission.

Company Information

Company

Hikma Pharmaceuticals PLC

Location

London, Ontario, Canada

About

Hikma helps put better health within reach every day for millions of people around the world. For more than 45 years, they've been creating high-quality medicines and making them accessible. Headquartered in the UK, Hikma has a global presence and focuses on transforming cutting-edge science into innovative solutions. Their range includes both branded and non-branded generic medicines.

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed

Related People

Hikma Completes Acquisition Of Custopharm

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

M&A Insights

Related People

Kristen hidden

Naoual hidden

Hana hidden

Company Information